Tamoxifen, an estrogen antagonist, can prevent ER-positive tumor development in women at risk of developing breast cancer. Mouse studies demonstrate that tamoxifen can prevent ER-negative tumors if administered to young mice. This project examined the differences in cell populations and progenitor activity between mammary organoids from young and old MMTV-c-neu mice, treated with or without tamoxifen. Tamoxifen-treatment increased the proportion of luminal, colony-forming cells in 2D but decreased the proportions of basal and CD61-positive, luminal progenitor cells in young and old mouse organoids. Tamoxifen tended to increase the proportions of CD61-negative, luminal cells in old organoids but reduced this population in young mouse organoids. In 3D cultures, tamoxifen increased the number of luminal-like colonies produced by old, but not young, mouse organoid cells. These results suggest that aging renders the CD61-negative, luminal cell population resistant to tamoxifen and that this population should be targeted for the prevention of ER-negative tumors.
University of Minnesota M.S. thesis. December 2020. Major: Biological Science. Advisors: Teresa Rose-Hellekant, Jon Holy. 1 computer file (PDF); vii, 93 pages.
The Effects of Tamoxifen on Mammary Organoids from Young and Old MMTV-c-neu Mice.
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.